ITIL-306 in Advanced Solid Tumors
Instil Bio
Instil Bio
Instituto do Cancer do Estado de São Paulo
National Cancer Institute (NCI)
OncoC4, Inc.
Genmab
University of Chicago
Exscientia AI Limited
Seagen Inc.
Mayo Clinic
SystImmune Inc.
Guardant Health, Inc.
Numab Therapeutics AG
Medicenna Therapeutics, Inc.
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Celldex Therapeutics
M.D. Anderson Cancer Center
Numab Therapeutics AG
Tempus AI
University of Pennsylvania